Hologic Newswire (Page 7)

Hologic Newswire (Page 7)

Comprehensive Real-Time News Feed for Hologic. (Page 7)

Results 121 - 140 of 823 in Hologic

  1. DiagnoCure Announces Closing Of The PCA3 Asset Sale Transaction And...Read the original story

    Feb 17, 2016 | BioSpace

    DiagnoCure Announces Closing Of The PCA3 Asset Sale Transaction And Special Distribution To Its Shareholders, By Way Of Due Bills, Of Proceeds From The Sale Of Its PCA3 Assets /PRNewswire/ - DiagnoCure Inc. announced today the closing of the previously announced sale of all assets related to DiagnoCure's PCA3 prostate cancer biomarker to Hologic, Inc. via its wholly-owned subsidiary, Gen-Probe Incorporated . In connection with the PCA3 Asset Sale, the Corporation has repurchased the 4,900,000 series A convertible preferred shares of DiagnoCure held by Gen-Probe Incorporated.

    Comment?

  2. Hologic, Inc. (HOLX) Stock Rating Reaffirmed by Piper JaffrayRead the original story w/Photo

    Feb 17, 2016 | AmericanBankingNews.com

    ... on the stock. Piper Jaffray's target price indicates a potential upside of 12.33% from the company's previous close. Hologic ( NASDAQ:HOLX ) traded up 1.611% during midday trading on Wednesday, reaching $34.375. 660,580 shares of the company's stock ...

    Comment?

  3. Research Analysts' Recent Ratings Changes for HologicRead the original story w/Photo

    Feb 15, 2016 | AmericanBankingNews.com

    1/28/2016 - Hologic was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $41.00 price target on the stock. They wrote, "HOLX's F1Q16 revenue and EPS beat consensus. Management lowered its FY16 ...

    Comment?

  4. Hologic, Inc. (Holx) Shares Sold by Dupont Capital Management CorpRead the original story w/Photo

    Feb 13, 2016 | AmericanBankingNews.com

    DUPONT CAPITAL MANAGEMENT Corp decreased its position in Hologic, Inc. by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 122,500 shares of the company's stock after selling 27,251 shares during the period.

    Comment?

  5. Frontier Capital Management Co. LLC Has $48,601,000 Position in Hologic, Inc.Read the original story w/Photo

    Feb 12, 2016 | AmericanBankingNews.com

    Frontier Capital Management Co. LLC increased its position in Hologic, Inc. by 35.3% during the fourth quarter, according to its most recent filing with the SEC.

    Comment?

  6. Short Interest in Hologic, Inc. (HOLX) Declines By 13.0%Read the original story w/Photo

    Feb 12, 2016 | AmericanBankingNews.com

    Hologic, Inc. saw a large decline in short interest in January. As of January 29th, there was short interest totalling 9,061,752 shares, a decline of 13.0% from the January 15th total of 10,413,993 shares, Analyst Ratings Net reports.

    Comment?

  7. Hanseatic Management Services Inc. Sells 174 Shares of Hologic, Inc.Read the original story w/Photo

    Feb 11, 2016 | AmericanBankingNews.com

    Hanseatic Management Services Inc. lowered its position in Hologic, Inc. by 0.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,602 shares of the company's stock after selling 174 shares during the period.

    Comment?

  8. Hologic, Inc. (Holx) Shares Bought by Gofen & Glossberg LLC IlRead the original story w/Photo

    Feb 11, 2016 | Daily Political

    Gofen & Glossberg LLC IL increased its position in shares of Hologic, Inc. by 72.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission . The institutional investor owned 16,385 shares of the company's stock after buying an additional 6,880 shares during the period.

    Comment?

  9. Graybill Bartz & Assoc Ltd. Cuts Stake in Hologic, Inc.Read the original story w/Photo

    Feb 9, 2016 | Daily Political

    Graybill Bartz & Assoc Ltd. cut its position in Hologic, Inc. by 45.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 58,130 shares of the company's stock after selling 48,775 shares during the period.

    Comment?

  10. Tracking Kahn Brothers Portfolio - Q4 2015 UpdateRead the original story w/Photo

    Feb 9, 2016 | Seeking Alpha

    ... accounts for 10.39% of the US long portfolio. Largest five positions are Citigroup Inc., Merck Inc., New York Times, Hologic Inc., and Pfizer Inc. Together, they account for 47.74% of the US long portfolio. Irving Kahn was a disciple of Benjamin ...

    Comment?

  11. DNB Asset Management Sells 10,400 Shares of Hologic, Inc.Read the original story w/Photo

    Feb 8, 2016 | AmericanBankingNews.com

    DNB Asset Management lowered its stake in Hologic, Inc. by 44.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,205 shares of the company's stock after selling 10,400 shares during the period.

    Comment?

  12. Hologic, Inc. (HOLX) Rating Reiterated by Piper JaffrayRead the original story w/Photo

    Feb 5, 2016 | AmericanBankingNews.com

    ... have recently added to or reduced their stakes in the company. 1st Global Advisors Inc. boosted its stake in Hologic by 2.6% in the fourth quarter. 1st Global Advisors Inc. now owns 17,721 shares of the company's stock valued at $686,000 after ...

    Comment?

  13. Hologic, Inc. (HOLX) Receives "Hold" Rating from Piper JaffrayRead the original story w/Photo

    Feb 5, 2016 | Daily Political

    Hologic traded down 4.17% during midday trading on Thursday, reaching $33.74. 1,654,188 shares of the company's stock were exchanged.

    Comment?

  14. Zacks: Analysts Anticipate Hologic, Inc. (NASDAQ:HOLX) to Post $0.45 Earnings Per ShareRead the original story w/Photo

    Feb 4, 2016 | Daily Political

    Wall Street analysts forecast that Hologic, Inc. will report earnings per share of $0.45 for the current quarter, according to Zacks . Eleven analysts have made estimates for Hologic's earnings.

    Comment?

  15. Dorsey Wright & Associates Takes Position in Hologic, Inc.Read the original story w/Photo

    Feb 4, 2016 | AmericanBankingNews.com

    Dorsey Wright & Associates acquired a new stake in shares of Hologic, Inc. during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 86,871 shares of the company's stock, valued at approximately $3,361,000.

    Comment?

  16. Weekly Research Analysts' Ratings Updates for HologicRead the original story w/Photo

    Feb 3, 2016 | AmericanBankingNews.com

    Several brokerages have updated their recommendations and price targets on shares of Hologic in the last few weeks: 1/28/2016 - Hologic was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $41.00 price target on the stock.

    Comment?

  17. 1st Global Advisors Inc. Has $686,000 Stake in Hologic, Inc.Read the original story w/Photo

    Feb 1, 2016 | AmericanBankingNews.com

    The firm owned 17,721 shares of the company's stock after buying an additional 441 shares during the period. 1st Global Advisors Inc.'s holdings in Hologic were worth $686,000 as of its most recent SEC filing.

    Comment?

  18. Hologic reports strong U.S. salesRead the original story w/Photo

    Feb 1, 2016 | Norwalk Citizen News

    Hologic reported a strong first quarter that included double digit growth of its breast-imaging technology sales in the United States but continued weakness overseas. Hologic, which has more than 300 employees locally at its research and development facility on the city's west side, said revenue even exceeded management's expectations as efforts were made to ramp up marketing and commercialization of products including the Selenia Dimensions 3D mammography system.

    Comment?

  19. Hologic, Inc. (HOLX) to Post FY2017 Earnings of $2.12 Per Share, Leerink Swann ForecastsRead the original story w/Photo

    Feb 1, 2016 | AmericanBankingNews.com

    Equities researchers at Leerink Swann raised their FY2017 earnings estimates for shares of Hologic in a report issued on Thursday, according to Zacks Investment Research . Leerink Swann analyst R. Newitter now forecasts that the brokerage will post earnings per share of $2.12 for the year, up from their previous forecast of $2.07.

    Comment?

  20. Hologic, Inc. (HOLX) Stock Rating Reaffirmed by William BlairRead the original story w/Photo

    Jan 31, 2016 | AmericanBankingNews.com

    ... Other hedge funds have added to or reduced their stakes in the company. Fox Run Management acquired a new stake in Hologic during the fourth quarter valued at approximately $302,000. Quotient Investors acquired a new stake in Hologic during the ...

    Comment?